Mylan plans to sell up to 92 million shares of Biocon Ltd, targeting proceeds of up to INR 34.81B (about $363M), per a Reuters term sheet. The announcement is a meaningful capital-markets move for Mylan/Biocon, but the overall impact is likely limited to the companies rather than the broader market.
Mylan plans to sell up to 92 million shares of Biocon Ltd, targeting proceeds of up to INR 34.81B (about $363M), per a Reuters term sheet. The announcement is a meaningful capital-markets move for Mylan/Biocon, but the overall impact is likely limited to the companies rather than the broader market.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
